MBK-01

BIOLOGICAL2 trials

Sponsors

Mikrobiomik Healthcare Company S.L.

Conditions

DiverticulitisDiverticulitis of SigmoidPrimary Clostridium Difficile InfectionRecurrent Clostridium Difficile Infection

Phase 2

Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis

RecruitingNCT06687382

Mikrobiomik Healthcare Company S.L.Diverticulitis, Diverticulitis of Sigmoid

Start: 2025-04-03End: 2027-04-30Target: 81Updated: 2025-06-05

Phase 3

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

CompletedNCT05201079

Mikrobiomik Healthcare Company S.L.Primary Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection

Start: 2021-10-29End: 2023-11-15Updated: 2025-03-25